HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case–control study
…, GC Zografos, A Antsaklis, AM Dimopoulos… - Molecular biology …, 2012 - Springer
This case control study aims to investigate the role of HSP90 Gln488His (C > G), HSP70-2
P1/P2, HIF-1 alpha C1772T and HSPA8 intronic 1541–1542delGT polymorphisms as …
P1/P2, HIF-1 alpha C1772T and HSPA8 intronic 1541–1542delGT polymorphisms as …
Pure infradiaphragmatic Hodgkin's lymphoma. Clinical features, prognostic factor and comparison with supradiaphragmatic disease
…, P Repoussis, P Roussou, AM Dimopoulos… - …, 2006 - haematologica.org
BACKGROUND AND OBJECTIVES: Pure infradiaphragmatic Hodgkin's lymphoma (HL) is a
rare disease. The prognostic impact of a purely infradiaphragmatic localization of this …
rare disease. The prognostic impact of a purely infradiaphragmatic localization of this …
[HTML][HTML] Gestational trophoblastic neoplasia with retroperitoneal metastases: a fatal complication
…, F Zagouri, I Chatzinikolaou, AM Dimopoulos… - World Journal of …, 2010 - Springer
Background Gestational Trophoblastic Neoplasia (GTN) is a pathologic entity that can affect
any pregnancy and develop long after the termination of the pregnancy. Its course can be …
any pregnancy and develop long after the termination of the pregnancy. Its course can be …
HTERT MNS16A polymorphism in breast cancer: a case–control study
…, GC Zografos, A Antsaklis, AM Dimopoulos… - Molecular biology …, 2012 - Springer
This case–control study aims to investigate the role of HTERT MNS16A polymorphism as a
potential risk factors and/or a prognostic marker for breast cancer. 113 consecutive incident …
potential risk factors and/or a prognostic marker for breast cancer. 113 consecutive incident …
Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative …
DV Skarlos, AM Dimopoulos, P Kosmidis… - Lung Cancer, 2003 - Elsevier
There is some evidence that taxanes and gemcitabine are effective antitumor agents against
small-cell lung cancer (SCLC). A total of 20 chemotherapy-naive patients with extensive …
small-cell lung cancer (SCLC). A total of 20 chemotherapy-naive patients with extensive …
Hemophagocytic lymphohistiocytosis after chemotherapy for multiple myeloma
…, MI Anastasiou-Nana, AM Dimopoulos - Clinical Lymphoma, 2004 - Elsevier
Secondary hemophagocytic lymphohistiocytosis has been reported after infections in
immunocompromised hosts or in association with several malignancies. We report a case of …
immunocompromised hosts or in association with several malignancies. We report a case of …
A cytokine cocktail augments the efficacy of adoptive NK-92 cell therapy against mouse xenografts of human cancer
…, C Gouloumis, W Voelter, AM Dimopoulos… - Anticancer …, 2016 - ar.iiarjournals.org
Background/Aim: Peripheral blood mononuclear cells (PBMCs) activated with immobilized
monoclonal antibody against cluster of differentiation 3 (CD3) secrete cytokines in their …
monoclonal antibody against cluster of differentiation 3 (CD3) secrete cytokines in their …
Dose-Dense Sequentials Chemotherapy with Epirubicin and Paclitaxel in Advanced Breast Cancer
E Razis, AM Dimopoulos, D Bafaloukos… - Cancer …, 2001 - Taylor & Francis
The purpose of this study was to evaluate the activity and toxicity profile of dose-dense
sequential chemotherapy with epirubicin (EPI) and paclitaxel in advanced breast cancer (ABC). …
sequential chemotherapy with epirubicin (EPI) and paclitaxel in advanced breast cancer (ABC). …
Energy at sea: Old Problems, New Challenges An international Conference
AM Dimopoulos - 2015 - energyatsea.law.uoa.gr
… Professor Athanassios-Meletios Dimopoulos, Rector, National & Kapodistrian University …